Research Recommendations Snapshot - April 2024
These recommendations offer diverse perspectives on the performance of various companies, ranging from positive to neutral and negative outlooks. Each assessment includes target prices and ratings, providing valuable insights for investors. Whether it's a buy, sell, or hold recommendation, these insights guide investors in making informed decisions about these stocks.
1. SAMIL (Sundram Fasteners Ltd):
- Morgan Stanley recommends maintaining an overweight position on the company with a target price of Rs 133 per share, expressing a positive outlook.
2. HDFC Life:
- Morgan Stanley suggests maintaining an overweight position with a target price of Rs 745 per share, indicating a positive stance.
3. Bajaj Auto:
- JP Morgan advises maintaining an overweight position and raising the target price to Rs 10,000 per share, expressing a positive sentiment.
- Jefferies also recommends buying the stock with a target price of Rs 10,500 per share, reflecting a positive outlook.
4. Apollo Hospitals:
- HSBC suggests maintaining a buy position on Apollo Hospitals with a raised target price of Rs 7,475 per share, showing a positive sentiment.
5. TVS Motors:
- Citi maintains a sell recommendation on TVS Motors but raises the target price to Rs 1,450 per share, expressing a neutral stance.
6. Axis Bank:
- Jefferies advises maintaining a buy position on Axis Bank with a target price of Rs 1,380 per share, reflecting a neutral stance.
7. Infosys:
- MOSL maintains a buy recommendation with a target price of Rs 1,650 per share, expressing a neutral stance.
- JP Morgan suggests maintaining an overweight position with a target price of Rs 1,700 per share, reflecting a neutral stance.
- Jefferies maintains a buy recommendation with a target price of Rs 1,630 per share, expressing a neutral stance.
- UBS maintains a buy recommendation with a target price of Rs 1,700 per share, indicating a neutral stance.
- Investec advises holding the stock with a target price of Rs 1,540 per share, expressing a negative sentiment.
- CLSA maintains an outperform recommendation but cuts the target price to Rs 1,550 per share, reflecting a negative stance.
- Nomura maintains a neutral recommendation but cuts the target price to Rs 1,400 per share, expressing a negative stance.
- Macquarie maintains an underperforming recommendation with a target price of Rs 1,160 per share, reflecting a negative stance.
8. TCS (Tata Consultancy Services):
- JP Morgan upgrades to overweight with a target price of Rs 4,500 per share, reflecting a positive sentiment.
- Goldman Sachs maintains a buy recommendation with a target price of Rs 4,350 per share, indicating a positive stance.
- Morgan Stanley suggests maintaining an overweight position with a target price of Rs 4,350 per share, expressing a positive sentiment.
- UBS maintains a buy recommendation with a target price of Rs 4,700 per share, expressing a positive sentiment.
- HSBC maintains a buy recommendation with a target price of Rs 4,540 per share, showing a positive sentiment.
- Jefferies suggests holding the stock with a target price of Rs 4,030 per share, reflecting a neutral stance.
- CLSA maintains a hold recommendation but cuts the target price to Rs 4,043 per share, indicating a neutral stance.
- Nomura maintains a reduced recommendation but raises the target price to Rs 3,240 per share, expressing a neutral stance.
9. Sun Pharma:
- HSBC maintains a buy recommendation with a target price of Rs 1,790 per share, showing a positive sentiment.
10. Dixon:
- HSBC suggests maintaining a buy position with a target price of Rs 8,400 per share, expressing a positive sentiment.
11. Indian Hotels:
- UBS recommends maintaining a buy position with a raised target price of Rs 715 per share from Rs 500 per share, showing a positive sentiment.
12. ONGC:
- Jefferies initiates a buy recommendation with a target price of Rs 390 per share, expressing a positive sentiment.
13. Zomato:
- UBS maintains a buy recommendation with a raised target price of Rs 250 per share, indicating a positive stance.
14. Exide:
- Morgan Stanley suggests maintaining an overweight position with a raised target price of Rs 485 per share from Rs 373 per share, expressing a positive sentiment.
15. Cyient DLM:
- Kotak recommends maintaining a sell position with a target price of Rs 570 per share, indicating a neutral stance.
WhatsApp Group for Investment Ideas+ IPO Updates
DISCLAIMER: No financial information whatsoever published anywhere here should be construed as an offer to buy or sell securities, or as advice to do so in any way whatsoever. All matters published here are purely for educational and information purposes only and under no circumstances should be used for making investment decisions. Readers must consult a qualified financial advisor before making any actual investment decisions, based on the information published here. Any reader making decisions based on any information published here does so entirely at their own risk. Investors should bear in mind that any investment in the stock market is subject to unpredictable market-related risks. The author has no plans to invest in this offer and also the author does not recommend investing in any offer published on this website.